Oppenheimer raised its price target on Vertex (NASDAQ: VRTX) to $200.00 (from $180.00) while maintaining an Outperform rating following results.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Vertex (VRTX) PT Raised to $211 at Morgan StanleyJuly 26, 2018 9:03 AM Vertex (VRTX) PT Raised to $203 at RBC CapitalJuly 26, 2018 8:44 AM Vertex (VRTX) PT Raised to $204 at BMO Capital; 'Stellar Revenue'July 26, 2018 7:11 AM Vertex (VRTX) PT Raised to $188 at UBSJuly 26, 2018 7:07 AM Vertex Pharma (VRTX) Tops Q2 EPS by 19c; Raises OutlookJuly 25, 2018 4:03 PM Vertex Reports Second-Quarter 2018 Financial ResultsJuly 25, 2018 4:01 PM